Clinical Trials Directory

Trials / Completed

CompletedNCT00418106

Kangaroo Holding Effects on Breast Milk

Early Kangaroo Holding Effects on Breast Milk Composition

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Christiana Care Health Services · Academic / Other
Sex
All
Age
14 Days
Healthy volunteers
Accepted

Summary

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of this study is to determine if kangaroo holding a baby changes the amount and composition of breast milk pumped before and after the kangaroo holding session. Hypotheses: 1. There is a significant difference in volume of maternal breast milk pumped after kangaroo holding premature infants as compared to maternal breast milk pumped after non-holding conditions 2. There is a significant difference in the composition of maternal breast milk pumped after kangaroo holding premature infants as compared to maternal breast milk pumped after non-holding condition.

Detailed description

This study will address two of the overwhelming challenges in the physiologic care of premature infants in the neonatal intensive care unit (NICU) environment. The first challenge is promoting neonatal growth through providing a careful balance of nutrition to caloric expenditure for premature infants. The second challenge is supporting parents in the intensive, technology driven environment of the NICU to merge physiologic care with parental-infant interaction through touch, communication, and maternal intervention. The vast majority of mothers with premature infants express breast milk for early feedings, however milk production tends to diminish three to four weeks after delivery. The practice of skin-to-skin holding is thought to promote the mother's ability to produce breast milk, but had not been empirically tested. This study will examine the relationship of kangaroo holding on mother's breast milk production and composition.

Conditions

Timeline

Start date
2005-11-01
Primary completion
2006-12-01
Completion
2006-12-01
First posted
2007-01-04
Last updated
2008-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00418106. Inclusion in this directory is not an endorsement.